Avalyn Pharma vs Pulmocide
Avalyn Pharma
Revolutionizing respiratory care with every breath
58 employees · est. 2011 · Boston, United States
Pulmocide
Developing best-in-class inhaled medicines for targeted treatment of life-threatening respiratory diseases
25 employees · est. 2013 · London, United Kingdom
Avalyn Pharma is the older company (2011 vs 2013); Avalyn Pharma is the larger of the two.
Side-by-Side Comparison
| Metric | Avalyn Pharma | Pulmocide |
|---|---|---|
| Founded | ||
| Founded | 2011 older | 2013 |
| Headquarters | ||
| Headquarters | Boston, United States | London, United Kingdom |
| Employees | ||
| Employees | 58 larger | 25 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biotechnology, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Series C | Series C |
| Total Funding | ||
| Total Funding | $272.50M | $194.90M |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Services | ||
| Services | Development of inhaled therapies, Drug delivery solutions, Clinical trials | Development of Novel Inhaled Medicines, Clinical Development of Opelconazole, Treatment for Invasive Pulmonary Aspergillosis, Research on Aspergillus-related Conditions |
| Target Customers | ||
| Target Customers | Patients with rare lung diseases, Healthcare providers, Biopharmaceutical investors | Patients with Invasive Pulmonary Aspergillosis, Healthcare Providers, Medical Researchers, Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | Pulmonary Fibrosis TreatmentRespiratory CareInhaled FormulationsInterstitial Lung DiseasesPirfenidoneNintedanib +9 | BiopharmaceuticalsRespiratory DiseasesInhaled MedicinesFungal InfectionsPulmonary AspergillosisLung Transplant +5 |
| Website | ||
| Website | avalynpharma.com | pulmocide.com |
About Avalyn Pharma
Avalyn Pharma, founded in 2011 and headquartered in the United States, is pioneering advancements in the treatment of pulmonary fibrosis. With the slogan, “Revolutionizing respiratory care with every breath,” Avalyn is focused on creating innovative inhaled therapies. The company is reshaping respi...
About Pulmocide
Pulmocide, a biopharmaceutical company founded in 2013 and based in the United Kingdom, is pioneering the development of inhaled medicines for the targeted treatment of life-threatening respiratory diseases. Their core focus is on serious respiratory fungal infections, particularly pulmonary aspergi...
Also comparing in this category
Comparing more than these two?
Get Avalyn Pharma, Pulmocide and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Avalyn Pharma compare?
A PDF of Avalyn Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Avalyn Pharma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Avalyn Pharma on 11 Mar 2026, and Pulmocide on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
